Ranizurel 0.5mg Injection
Marketer
Reliance Life Sciences
Salt Composition
Ranibizumab (0.5mg)
Overview Ranizurel 0.5mg Injection
Diabetic retinopathy, macular degeneration, and macular edema are treated with a 0.5mg Ranizurel injection. This medication targets abnormal blood vessel growth and leakage within the eye, mitigating potential vision impairment. Administration is strictly via intraocular injection by an ophthalmologist; self-injection is prohibited. Potential side effects include conjunctival bleeding, ocular pain, floaters, elevated intraocular pressure, and eye inflammation. Persistent side effects or any concerning symptoms necessitate immediate physician consultation. Post-injection driving is discouraged due to potential visual disturbances.
Uses of Ranizurel 0.5mg Injection
Eye conditions associated with diabetes, wet macular degeneration, and retinal vein occlusion-related macular swelling.
Major Benefits of Ranizurel 0.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ranizurel 0.5mg Injection:
- Conjunctival hemorrhage
- Eye pain
- Increased intraocular pressure
- Foreign body sensation in eyes
- Blurred vision
- Nausea
- Dry eye
- Eye itching
- Cataract
- Vitreous floaters
- Vitreous detachment
- Intraocular inflammation
- Eye irritation
- Increased lacrimation
- Eyelid inflammation
- Ocular hyperemia
- Retinal disorder
- Maculopathy
- Eye discomfort
- Posterior capsule opacification
- Injection site hemorrhage
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Anemia (low number of red blood cells)
- Joint pain
- Renal failure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Gastro-esophageal reflux disease
- Hypercholesterolemia (high cholesterol)
- Bronchitis (inflammation of the airways)
How to use Ranizurel 0.5mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Ranizurel 0.5mg Injection works:
Ranizurel 0.5mg Injection, an anti-angiogenesis agent, inhibits vascular endothelial growth factor (VEGF), a protein crucial for abnormal blood vessel formation. This action prevents the growth and leakage of these vessels within the eye(s), thereby mitigating potential vision impairment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ranizurel 0.5mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Ranizurel 0.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Ranizurel 0.5mg Injection safely. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Following administration of Ranizurel 0.5mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneySAFE IF PRESCRIBED
Administering Ranizurel 0.5mg Injection to individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Ranizurel 0.5mg Injection in individuals with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary. Physician consultation is advised.
What if you forget to take Ranizurel 0.5mg Injection :
Omit a dose of Ranizurel 0.5mg Injection? Seek your physician's advice.
Facts to Know About Ranizurel 0.5mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Action Class | AMD treatment with a VEGF inhibitor |
3,018 People bought this recently